Biology of Blood and Marrow Transplantation
Volume 16, Issue 8 , Pages 1138-1144 , August 2010

Predictors of Late Cardiovascular Complications in Survivors of Hematopoietic Cell Transplantation

  • Saro H. Armenian

      Affiliations

    • Department of Population Sciences, City of Hope, Duarte, California
    • ,
  • Can-Lan Sun

      Affiliations

    • Department of Population Sciences, City of Hope, Duarte, California
    • ,
  • George Mills

      Affiliations

    • Department of Population Sciences, City of Hope, Duarte, California
    • ,
  • Jennifer Berano Teh

      Affiliations

    • Department of Population Sciences, City of Hope, Duarte, California
    • ,
  • Liton Francisco

      Affiliations

    • Department of Population Sciences, City of Hope, Duarte, California
    • ,
  • Jean-Bernard Durand

      Affiliations

    • Department of Cardiology, University of Texas M.D. Anderson Cancer Center, Houston, Texas
    • ,
  • F. Lennie Wong

      Affiliations

    • Department of Population Sciences, City of Hope, Duarte, California
    • ,
  • Stephen J. Forman

      Affiliations

    • Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California
    • ,
  • Smita Bhatia

      Affiliations

    • Department of Population Sciences, City of Hope, Duarte, California
    • Corresponding Author InformationCorrespondence and reprint requests: Smita Bhatia, MD, MPH, City of Hope, 1500 East Duarte Road, Duarte, CA 91010-3000.

Received 22 January 2010 ,Accepted 21 February 2010.

References 

  1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354:1813–1826
  2. Syrjala KL, Langer SL, Abrams JR, et al. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol. 2005;23:6596–6606
  3. Baker KS, Ness KK, Steinberger J, et al. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplantation Survivor Study. Blood. 2007;109:1765–1772
  4. Bhatia S, Ramsay NK, Steinbuch M, et al. Malignant neoplasms following bone marrow transplantation. Blood. 1996;87:3633–3639
  5. Armenian SH, Bhatia S. Cardiovascular disease after hematopoietic cell transplantation: lessons learned. Haematologica. 2008;93:1132–1136
  6. Tichelli A, Bhatia S, Socie G. Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation. Br J Haematol. 2008;142:11–26
  7. Tichelli A, Passweg J, Wojcik D, et al. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late- Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica. 2008;93:1203–1210
  8. Tichelli A, Bucher C, Rovo A, et al. Premature cardiovascular disease after allogeneic hematopoietic stem cell transplantation. Blood. 2007;110:3463–3471
  9. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–1847
  10. Grundy SM, Pasternak R, Greenland P, et al. AHA/ACC scientific statement. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol. 1999;34:1348–1359
  11. Bhatia S, Francisco L, Carter A, et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood. 2007;110:3784–3792
  12. Majhail NS, Ness KK, Burns LJ, et al. Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study. Biol Blood Marrow Transplant. 2007;13:1153–1159
  13. Coplin WM, Cochran MS, Levine SR, et al. Stroke after bone marrow transplantation: frequency, aetiology and outcome. Brain. 2001;124:1043–1051
  14. Lehmann S, Isberg B, Ljungman P, et al. Cardiac systolic function before and after hematopoietic stem cell transplantation. Bone Marrow Ttransplant. 2000;26:187–192
  15. Le Deley MC, Leblanc T, Shamsaldin A, et al. Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Societe Francaise d'Oncologie Pediatrique. J Clin Oncol. 2003;21:1074–1081
  16. Tucker MA, Meadows AT, Boice JD, et al. Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst. 1987;78:459–464
  17. Sheridan S, Pignone M, Mulrow C. Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians. J Gen Intern Med. 2003;18:1039–1052
  18. Luepker RV, Apple FS, Christenson RH, et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention, AHA Statistics Committee, World Heart Federation Council on Epidemiology and Prevention, European Society of Cardiology Working Group on Epidemiology and Prevention, Centers for Disease Control and Prevention, and the National Heart, Lung, and Blood Institute. Circulation. 2003;108:2543–2549
  19. Cannon CP, Battler A, Brindis RG, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes: a report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol. 2001;38:2114–2130
  20. Krumholz HM, Brindis RG, Brush JE, et al. Standards for statistical models used for public reporting of health outcomes: an American Heart Association Scientific Statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group, cosponsored by the Council on Epidemiology and Prevention and the Stroke Council, endorsed by the American College of Cardiology Foundation. Circulation. 2006;113:456–462
  21. Elkind MS. Inflammation, atherosclerosis, and stroke. Neurologist. 2006;12:140–148
  22. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685–1695
  23. Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke. 2006;37:1923–1932
  24. Aleman BM, van den Belt-Dusebout AW, De Bruin ML, et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood. 2007;109:1878–1886
  25. Hooning MJ, Botma A, Aleman BM, et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst. 2007;99:365–375
  26. van den Belt-Dusebout AW, Nuver J, de Wit R, et al. Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol. 2006;24:467–475
  27. Yahalom J, Portlock CS. Long-term cardiac and pulmonary complications of cancer therapy. Hematol Oncol Clin North Am. 2008;22:305–318
  28. Carver JR, Shapiro CL, Ng A, et al. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol. 2007;25:3991–4008
  29. Bowers DC, McNeil DE, Liu Y, et al. Stroke as a late treatment effect of Hodgkin's disease: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2005;23:6508–6515
  30. De Bruin ML, Dorresteijn LD, van't Veer MB, et al. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst. 2009;101:928–937
  31. Taskinen M, Saarinen-Pihkala UM, Hovi L, et al. Impaired glucose tolerance and dyslipidaemia as late effects after bone marrow transplantation in childhood. Lancet. 2000;356:993–997
  32. Annaloro C, Usardi P, Airaghi L, et al. Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant. 2008;41:797–804
  33. Majhail NS, Flowers ME, Ness KK, et al. High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 009;43:49–54.
  34. Armenian SH, Sun CL, Francisco L, et al. Late congestive heart failure after hematopoietic cell transplantation. J Clin Oncol. 2008;26:5537–5543
  35. Dorresteijn LD, Kappelle AC, Boogerd W, et al. Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol. 2002;20:282–288
  36. Hull MC, Morris CG, Pepine CJ, et al. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA. 2003;290:2831–2837
  37. Landier W, Bhatia S, Eshelman DA, et al. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol. 2004;22:4979–4990
  38. Rizzo JD, Wingard JR, Tichelli A, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2006;12:138–151
  39. Braverman AC, Antin JH, Plappert MT, et al. Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. J Clin Oncol. 1991;9:1215–1223
  40. Woywodt A, Scheer J, Hambach L, et al. Circulating endothelial cells as a marker of endothelial damage in allogeneic hematopoietic stem cell transplantation. Blood. 2004;103:3603–3605
  41. Zeng L, Yan Z, Ding S, et al. Endothelial injury, an intriguing effect of methotrexate and cyclophosphamide during hematopoietic stem cell transplantation in mice. Transplant Proc. 2008;40:2670–2673
  42. Bishop MM, Lee SJ, Beaumont JL, et al. The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared to matched controls. Biol Blood Marrow Transplant. 2010;16:207–214

 Financial disclosure: See Acknowledgments on page 1143.

PII: S1083-8791(10)00094-7

doi: 10.1016/j.bbmt.2010.02.021

Biology of Blood and Marrow Transplantation
Volume 16, Issue 8 , Pages 1138-1144 , August 2010

Article Tools